openPR Logo
Press release

Cardiac Monitoring Devices Market – Increasing FDA clearance for new and innovative products By Leading Companies: Philips Healthcare, Medtronic, Boston Scientific, Cardiac Science, LifeWatch, CareTaker Medical, Spacelabs, St. Jude Medical, Kohden, Card

04-17-2019 12:31 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Cardiac Monitoring Devices

Cardiac Monitoring Devices

The FDA approved wireless continuous non-invasive 'Beat-by-Beat' blood pressure and heart rate monitor manufactured by CareTaker Medical based on patented finger cuff technology. The device allows physicians to remotely monitor medical-grade continuous blood pressure and heart rate from anywhere, using only a patient friendly-finger cuff.

Development of advance cardiac monitoring devices such as remote cardiac monitoring devices and wireless cardiac monitoring devices providing early detection is a major factor expected to boast the cardiac monitoring devices market growth over the forecast period. For instance, ZywiePro, the next-generation cardiac remote monitoring solution launched in 2015, leverages mobile and cloud technology to facilitate detection of cardiovascular arrhythmias. ZywiePro enables physicians to provide more personalized and effective patient care by detailed diagnostic insight into the cardiovascular health of the patients. However, factors inhibiting the cardiac monitoring devices market include high cost of device and lack of knowledge about advance cardiac monitoring devices.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/1272

Advance cardiac monitoring devices enable physician to make accurate diagnosis and determine a treatment plan. For instance, the Reveal LINQ Insertable Cardiac Monitor manufactured by Medtronic, approved by FDA in 2014, is currently the smallest heart monitor in the market. It can diagnose the cause of infrequent, unexplained fainting spells better than conventional testing.

According to the American Heart Association (AHA), 2017, about 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. AHA also stated in its report, that direct and indirect costs of cardiovascular diseases and stroke are estimated to account for US$ 316 billion, including health expenditures and lost productivity. Growth in Europe market is driven by emergence of innovative cardiac solutions offered by regional manufacturers and rising cases of cardiovascular diseases.

For instance, LifeWatch —manufacturer of two innovative Mobile Cardiac Telemetry (MCT) solutions — LifeWatch MCT 3 Lead and LifeWatch MCT 1 Lead Patch detects, records, and wirelessly transmits asymptomatic and symptomatic arrhythmia to clinicians for analysis. According to European Heart Network and European Society of Cardiology 2015, over 85 million people suffer from cardiovascular disease (CVD) every year, causing over 4 million deaths in Europe.

Request for Customization of Research @ https://www.coherentmarketinsights.com/insight/request-customization/1272

Rise in incidence of cardiovascular diseases such as cardiac arrthymia, ischemic heart disease, and hypertension is expected to fuel growth of the cardiac monitoring devices market. According to World Health Organization (WHO), 2015, cardiovascular diseases was the leading cause of deaths accounting for 17.7 million deaths, globally. Furthermore, increasing applications of cardiac monitors in continuous monitoring for patients with severe electrolyte imbalances and for postoperative observation is expected to augment the market growth over the forecast period.

Asia Pacific is also expected to witness high growth. This is attributed to availability of technological advanced products and rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of whom 2.9 million may suffer from AF-associated strokes.

Inquire about Discount on this Report @ https://www.coherentmarketinsights.com/insight/request-discount/1272

Key players in cardiac monitoring devices market are Philips Healthcare, Medtronic, Boston Scientific, Cardiac Science, LifeWatch, CareTaker Medical, Spacelabs, St. Jude Medical, Kohden, CardioNet, and Mortara Instrument.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Monitoring Devices Market – Increasing FDA clearance for new and innovative products By Leading Companies: Philips Healthcare, Medtronic, Boston Scientific, Cardiac Science, LifeWatch, CareTaker Medical, Spacelabs, St. Jude Medical, Kohden, Card here

News-ID: 1706943 • Views:

More Releases from Coherent Market Insights

Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clasado Biosciences, VW-Ingredients, Shandong Longli Biotechnology Co., Ltd, Prenexus Health., Ingredion, Tata Chemicals Ltd., Yakult Honsha Co., Ltd., Tate & Lyle, Roquette Frèr
Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clas …
Coherent Market Insights Published Most recent Prebiotics for Dietary Supplements Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business,
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., K
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca P …
Coherent Market Insights Published Most recent DNA Repair Drugs Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, Manufacturing Process, Business Plan | Alpek S.A.B de C.V., RTP Company, BASF SE
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, M …
This comprehensive Report of the Polyethylene Terephthalate (PET) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requirement | BASF SE, Occidental Chemical Corporation
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requi …
This comprehensive Report of the Chlorine Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size

All 5 Releases


More Releases for Cardiac

Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Prophesy in 2025
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are